AC/DC x Harle Tsu: A Comprehensive Strain Guide

Introduction and Overview

AC/DC x Harle Tsu is a purpose-bred, CBD-dominant cannabis cultivar created by crossing two of the most respected high-CBD lines: AC/DC and Harle-Tsu. It is engineered for a very high CBD:THC ratio, clear-headed functionality, and a gentle, non-intoxicating experience that appeals to wellness users and daytime consumers.

Growers and patients seek this cross because it consistently tests with double-digit CBD and sub-1% THC in many phenotypes. When properly selected, phenos commonly exhibit CBD content in the 12–18% range and total THC between 0.2–1.2% by dry weight, delivering ratios from 15:1 up to 30:1 and, in rare cases, even higher.

History and Genetic Lineage

AC/DC is widely reported to be a phenotype of Cannatonic (by Resin Seeds) that was selected in Northern California for exceptionally high CBD and minimal THC. Its claim to fame is a CBD:THC ratio that can exceed 20:1, with early analyses often showing ~14–18% CBD and ~0.5–1% THC.

Harle-Tsu originates from Southern Humboldt Seed Collective and traces to Harlequin x Sour Tsunami, two of the earliest and most influential CBD parents in the modern market. The late Lawrence Ringo is often credited for foundational work with Sour Tsunami and for helping popularize CBD-forward breeding in the Emerald Triangle.

Crossing AC/DC with Harle-Tsu reinforces the CBD trait from both sides of the family tree and adds vigor and structure that AC/DC sometimes lacks. Breeders and growers report that AC/DC x Harle Tsu produces more uniform, bushier plants than a pure AC/DC cut, with improved yields and slightly denser flowers while preserving ultra-low THC.

As CBD interest surged in the 2012–2018 period, this combination emerged as a reliable route to medicinal chemotypes without heavy intoxication. Today, it is a staple for small craft growers and patient collectives seeking lab-verified high-CBD flower that can meet functional wellness needs.

Appearance and Morphology

Mature AC/DC x Harle Tsu plants are medium-tall with a hybrid architecture: stronger lateral branching from the Harle-Tsu side and narrower leaflets nodding to AC/DC’s sativa-leaning ancestry. Internodal spacing is moderate, and with topping, plants often build a broad, multi-cola canopy that supports even light distribution.

The flowers are elongated and slightly spear-shaped, with a calyx-forward structure that trims cleanly. Most phenos display olive to bright spring-green bracts, amber to tangerine pistils, and a fine dusting of milky trichomes that can give the buds a silvered, satin finish.

While CBD cultivars historically had a reputation for lighter resin, modern AC/DC x Harle Tsu phenos can be surprisingly frosty. Trichome density is visibly high under magnification, with capitate-stalked heads abundant across the bract surfaces and sugar leaves, aiding both potency and extractability.

Stems are moderately robust and respond well to support in late flower when colas gain weight. Outdoor plants typically reach 5–7 feet with training, while indoor plants stay 30–48 inches depending on container size and veg duration.

Aroma and Flavor

Freshly broken buds often open with clean citrus and sweet herb notes—think lemon zest, green apple skin, and lemongrass. Underneath, you’ll likely find a steady base of pine resin and cedar, accented by cracked black pepper from beta-caryophyllene.

On the palate, this cross tends toward bright and botanical rather than heavy or gassy. Users frequently report tastes of Meyer lemon and sweet basil at first draw, shifting to earthy tea, pine needles, and light honey in the finish.

Vaporization at lower temperatures (170–185°C) highlights the limonene and pinene sparkle, keeping the profile crisp and refreshing. Combustion or hotter vapor settings (190–205°C) bring forward spicier, woodier tones from caryophyllene and humulene, with a subtle, almost chamomile-like softness from secondary terpenes.

Cannabinoid Profile and Ratios

Across verified reports for AC/DC x Harle Tsu, CBD typically falls between 12–18% by dry weight, with outliers from 10–20% depending on phenotype, environment, and harvest maturity. THC usually remains at or below 1%, commonly testing 0.2–0.8% in dialed-in indoor runs, which yields CBD:THC ratios in the 15:1 to 30:1 range.

Total cannabinoids often land between 14–20%, reflecting prevalent CBDA alongside minor constituents. Many samples show CBC in the 0.3–0.6% range and CBG between 0.2–1.0%, with trace THCV or CBT occasionally detected.

To translate percentages into actual dose: a flower at 15% CBD contains roughly 150 mg CBD per gram. If a consumer inhales 50 mg of ground flower (about one small bowl), that’s approximately 7.5 mg of CBD delivered before accounting for combustion or vaporization efficiency.

Decarboxylation efficiency for CBD typically ranges 80–95% under controlled conditions; home extraction can be lower. In infused oils, measured delivery of 10–25 mg CBD per serving is common for this cultivar, with negligible THC per serving for most phenotypes.

Terpene Profile and Aromatics Chemistry

While terpene totals vary by grow and cure, AC/DC x Harle Tsu often expresses 1.5–2.5% total terpenes by dry weight in optimized indoor conditions. Outdoor sun-grown can match or exceed this when handled carefully, especially with slow, cool curing.

Dominant terpenes are frequently myrcene (2–4 mg/g), beta-caryophyllene (1.5–3 mg/g), alpha- and beta-pinene combined (1–2 mg/g), and limonene (0.8–1.5 mg/g). Secondary contributors include humulene (0.5–1 mg/g), bisabolol (0.2–0.6 mg/g), and occasional ocimene or terpinolene traces that add floral-lilac or herbal brightness.

Myrcene contributes the gentle herbal-tea and soft fruit undercurrent, potentially supporting a calm body feel without heavy sedation. Beta-caryophyllene, a dietary terpene known to interact with CB2 receptors, lends peppery spice and may complement CBD’s non-intoxicating relaxation.

Pinene keeps the bouquet fresh and forested while limonene provides the citrus pop that many users perceive as mood-lifting. The result is a clean, restorative aromatic signature that’s easy to recognize in a jar lineup and pleasant to microdose throughout the day.

Experiential Effects and Use Cases

Expect a clear, level-headed onset with minimal intoxication due to the very low THC. Inhalation effects typically begin within 5–10 minutes, peak around 30–45 minutes, and taper over 2–3 hours.

Users commonly describe a gentle mental quieting and physical ease that does not impede focus or coordination. Compared to THC-dominant varieties, reported side effects are milder, with dry mouth and dry eyes the most prevalent; lightheadedness is uncommon and usually associated with dehydration or overconsumption.

For oral ingestion, onset is slower—45–90 minutes—with a steady plateau lasting 4–8 hours depending on dose and meal timing. Many consumers stack small doses (e.g., 5–10 mg CBD per serving) throughout the day to maintain consistent effects without fatigue.

Functionally, this strain suits work, study, errands, and social activities where clarity is important. It is also popular as a “bridge” cultivar for THC-sensitive individuals who still want the ritual and flavor of whole-flower cannabis without a mental high.

Potential Therapeutic Applications

CBD has been studied for a range of potential benefits, and AC/DC x Harle Tsu delivers CBD in a whole-plant matrix with complementary terpenes and minor cannabinoids. In randomized trials involving public-speaking stress, single oral doses of 300–600 mg CBD reduced anxiety metrics versus placebo, suggesting anxiolytic potential in specific contexts.

In pediatric epilepsies such as Dravet syndrome and Lennox–Gastaut syndrome, CBD solution (Epidiolex) at 10–20 mg/kg/day produced median seizure reductions of roughly 37–42% compared with baseline in pivotal trials. While smoked or vaporized flower is not a substitute for prescription formulations, these data support CBD’s anticonvulsant properties in certain conditions under medical supervision.

Preclinical and early clinical literature indicates CBD may modulate inflammatory pathways relevant to arthritis and neuropathic pain, with human studies showing mixed but promising signals. Beta-caryophyllene and myrcene, common in this cultivar, have been explored for anti-inflammatory and analgesic activity in animal models, potentially contributing to a broader entourage effect.

Consumers often report benefits for stress, muscle tension, and sleep initiation when dosed appropriately in the evening. As with any therapeutic use, individuals should consult a healthcare professional, especially if taking CYP450-metabolized medications, because CBD can alter drug metabolism at higher doses.

Comprehensive Cultivation Guide

Environment and climate: AC/DC x Harle Tsu performs best in 68–80°F (20–27°C) day temperatures and 60–70°F (16–21°C) nights. Maintain 55–65% RH during veg and 45–50% in early flower, tapering to 42–45% in late flower to deter botrytis.

Light intensity: Target PPFD 400–600 µmol/m²/s in veg and 700–900 µmol/m²/s in flower for photosynthetic efficiency without undue stress. Daily light integral (DLI) around 35–45 mol/m²/day in veg and 40–55 mol/m²/day in bloom supports robust cannabinoid and terpene production.

Medium and pH: In soil, maintain pH 6.2–6.8; in coco/hydro, 5.7–6.1. Well-aerated mixes (e.g., peat/coco with 25–35% perlite or pumice) reduce overwatering risk and improve root-zone oxygenation.

Nutrition and EC: In veg, aim for EC 1.2–1.6 (600–800 ppm 0.5 scale), shifting to EC 1.5–1.8 early flower and tapering to 1.2–1.4 in late flower. CBD cultivars often dislike heavy nitrogen late bloom; emphasize calcium, magnesium, sulfur, and potassium for resin and terpene development.

Training: Top or FIM once or twice by week 3–4 of veg to encourage lateral branching. Low-stress training and a light SCROG create an even canopy; this cross responds well to 6–10 main colas per plant in a 3–5 gallon container.

Irrigation strategy: Water to 10–15% runoff in soilless systems, allowing mild dry-back between events. Overwatering elevates root disease risk and can dampen terpene expression; aim for consistent moisture without saturation.

Flowering time: Indoors, anticipate 8–9 weeks from the flip for most phenos, with some finishing at 56–63 days. Outdoors in the Northern Hemisphere, harvest usually falls late September to mid-October depending on latitude and microclimate.

Yield: Indoor yields of 1.5–2.5 oz/ft² (450–750 g/m²) are attainable with strong canopy management and high PPFD. Outdoor plants in 50–100 gallon beds can produce 1.0–2.5 lbs per plant when season length and nutrition are optimized.

Aroma control and airflow: Because this cross can produce dense tops in dialed environments, provide 0.5–1.0 m/s canopy airflow and 20–30 complete air exchanges per hour in sealed rooms. Two to three circulating fans per 4x4 tent help prevent microclimates that lead to powdery mildew.

Nutrient specifics: In bloom, a balanced NPK of roughly 1–2–2 early flower and 1–3–2 mid-flower works well, accompanied by 150–200 ppm Ca and 50–70 ppm Mg. Sulfur at 40–60 ppm supports terpene biosynthesis; avoid excess phosphorus late bloom as it can mute aromatics.

Flush and finish: For mineral salts, a 7–10 day low-EC finish enhances smoothness. In living soil, simply water with dechlorinated water and maintain microbial health—avoid drastic changes that shock the rhizosphere.

Integrated Pest and Disease Management

Preventive IPM is more efficient than treatment. Start with clean clones, quarantine new genetics for 10–14 days, and use yellow/blue sticky cards to monitor flying pests.

Common threats include spider mites, thrips, fungus gnats, and powdery mildew. Rotate biologicals such as Bacillus subtilis, Beauveria bassiana, and Streptomyces-based products, and deploy predatory mites (Amblyseius swirskii, Neoseiulus californicus) early.

For powdery mildew, sulfur vapors or wettable sulfur may be used only in veg and must be discontinued at least 21 days before harvest. Maintain leaf-surface VPD in the 1.0–1.5 kPa range to discourage mildew while sustaining transpiration.

Botrytis prevention hinges on airflow, RH control below ~50% in late flower, and avoidance of dense, wet canopies. Defoliate strategically—remove interior larf and lower foliage to enhance light penetration and reduce microclimate humidity.

Harvest, Drying, and Curing

Harvest timing is best judged by trichome maturity: target mostly cloudy heads with 5–10% amber for a balanced, clear effect. CBD strains can amber slightly earlier than THC-heavy types; sample multiple sites to avoid premature harvest.

Dry at 60°F (15.5°C) and 58–62% RH for 10–14 days with gentle 0.3–0.5 m/s airflow not directly on the flowers. This slow dry preserves monoterpenes like limonene and pinene, which otherwise volatilize quickly at higher temps.

Cure in airtight containers burped daily for the first week, then every few days for weeks 2–4. Target a stable water activity of 0.55–0.62 for long-term storage; properly cured flower retains aroma and potency for 6–12 months when stored at 60–65°F in darkness.

For extraction, decarboxylate at 230–240°F (110–116°C) for 45–75 minutes depending on batch size and moisture. Gentle decarb preserves more terpenes, and a follow-on infusion at 180–200°F (82–93°C) efficiently transfers cannabinoids into lipids.

Processing and Product Forms

AC/DC x Harle Tsu flower is popular for vaporization, pre-rolls, and solventless rosin where the low THC content is a selling point for daytime use. Solventless yields of 15–22% from high-quality, fresh-frozen material are achievable in terpene-rich phenos.

Cold ethanol and hydrocarbon extraction produce broad-spectrum concentrates with CBD frequently above 60–75% and THC under 2% in the extract matrix. Post-process remediation can further reduce THC to non-detectable if required by product format or jurisdiction.

For tinctures, MCT or olive oil carriers are common, with products standardized to 10–50 mg CBD per mL and minimal THC. Gummies and capsules enable precise microdosing; consumers often start at 5–10 mg CBD and titrate to effect, reflecting the cultivar’s gentle pharmacology.

Consumer Dosing, Onset, and Safety

Start low and go slow remains prudent. For inhalation, 1–2 small puffs equate to approximately 3–8 mg CBD depending on device, flower potency, and inhalation technique.

For oral ingestion, 5–10 mg CBD is a typical starting dose, with gradual increases every 2–3 days until desired effect. Many daily users find 20–40 mg CBD sufficient for routine stress or muscle ease, while clinical studies often use higher doses for specific conditions.

Safety profile for CBD is broadly favorable, but high doses can interact with medications via CYP3A4 and CYP2C19. Common side effects include dry mouth and mild GI upset; dizziness is uncommon at typical whole-flower doses.

Comparative Analysis with Parent Strains

Versus AC/DC alone, the AC/DC x Harle Tsu cross tends to be bushier with stronger lateral structure and slightly faster flowering by ~3–5 days. Yield potential is often 10–20% higher than AC/DC in the same room when trained aggressively.

Compared with Harle-Tsu, this cross preserves similar CBD dominance but with a brighter citrus-forward nose and a touch more pinene. THC is comparable or slightly lower on average, enhancing the high-ratio CBD:THC profile and keeping intoxication minimal.

In lab terms, a typical AC/DC cut might clock 14–16% CBD and 0.6–1.0% THC, while Harle-Tsu often shows 12–16% CBD and 0.5–0.9% THC. Well-selected AC/DC x Harle Tsu phenos can match or exceed 16% CBD while holding THC near 0.3–0.6%, a sweet spot for clear-headed functionality.

Aroma Chemistry and Sensory Pairings

The citrus-herbal top note